Artia Global Partners’s Novo Nordisk NVO Stock Holding History

Artia Global Partners’s Portfolio NVO Stock Details NVO Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2025 Q1	–	Sell	-200,000	Closed	-$17.2M	–	43
2024 Q4	$17.2M	Sell	200,000 -541,743	-73%	-$58.6M	6.15%	5
2024 Q3	$88.3M	Buy	741,743 +50,000	+7%	+$6.67M	24.07%	1
2024 Q2	$98.7M	Hold	691,743	–	–	19.09%	1
2024 Q1	$88.8M	Sell	691,743 -29,764	-4%	-$3.54M	17.85%	2
2023 Q4	$74.6M	Buy	721,507 +39,695	+6%	+$3.93M	21.72%	1
2023 Q3	$62M	Hold	681,812	–	–	25.78%	1
2023 Q2	$55.2M	Buy	681,812 +39,702	+6%	+$3.24M	19.02%	1
2023 Q1	$51.1M	Sell	642,110 -100,000	-13%	-$7.09M	18.88%	1
2022 Q4	$50.2M	Buy	+742,110	New	+$43.5M	19.14%	1

Other funds holding NVO

Jennison Associates New York $145B AUM 34.61% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return

Loomis, Sayles & Company Boston, Massachusetts $74.3B AUM 24.01% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Fisher Asset Management Camas, Washington $295B AUM 31.6% 1-Year Est. Return

Fayez Sarofim & Co Houston, Texas $39.1B AUM 15.14% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Folketrygdfondet Oslo Norway, Norway $5.64B AUM 47.16% 1-Year Est. Return

Capital International Investors Los Angeles, California $427B AUM 29.17% 1-Year Est. Return

TIM

Thornburg Investment Management Santa Fe, New Mexico $9.63B AUM 35.65% 1-Year Est. Return

Artia Global Partners's NVO Position: Q1 2025 in Review

Artia Global Partners sold out of Novo Nordisk (NVO) in Q1 2025, closing a stake of 200,000 shares — an estimated $17.2M sold.

Artia Global Partners first reported a position in NVO in Q4 2022 and held it in 9 quarters. The position peaked at $98.7M in Q2 2024. 1,528 funds tracked by Wall St. Rank hold NVO as of Q1 2025.

Artia Global Partners reported no remaining Novo Nordisk position as of Q1 2025 after selling out during the quarter.
Artia Global Partners sold 200,000 Novo Nordisk shares in Q1 2025, an estimated $17.2M.
Artia Global Partners first reported a position in Novo Nordisk in Q4 2022 and held it in 9 quarters.
Artia Global Partners's Novo Nordisk position peaked at $98.7M in Q2 2024.
1,528 funds tracked by Wall St. Rank held Novo Nordisk as of Q1 2025.

Based on Artia Global Partners's 13F filing for Q1 2025, filed 15 May 2025.